✨ Your Portfolio is fetched and updated from zerodha.

Divi's Laboratories Ltd.

DIVISLAB

Market Cap
₹1,59,265 Cr.
P/E
86.75

Divi's Laboratories Ltd.

About
Divi's Laboratories Limited is a key player in the pharmaceutical industry, specializing in the production of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceutical ingredients. Th… Read more
Divi's Laboratories Limited is a key player in the pharmaceutical industry, specializing in th… Read more
Low
3350
52W Range
High
6276
  • Divi's Lab
  • Laurus Labs
  • Neuland Laboratories
  • TJI Pharma - API & CRAMS

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Brand Wise Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Suppliers
    • Neogen Chemicals Ltd.
    • HLE Glascoat Ltd.
    • Tatva Chintan Pharma Chem Ltd.
    FAQs on Divi's Laboratories Ltd. Business

    Divi's Laboratories Limited is a global pharmaceutical company specializing in the manufacturing of API's, Intermediates, and Nutraceutical ingredients for exports. It also offers custom synthesis services to innovator pharma companies for their patented products.

    Divi's Lab major competitors are Laurus Labs, Neuland Laboratories, Glenmark Life Scienc, Granules India, Shilpa Medicare, AMI Organics, Aarti Pharmalabs.
    Market Cap of Divi's Lab is ₹1,52,494 Crs.
    While the median market cap of its peers are ₹12,941 Crs.

    Divi's Lab seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice
    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Sep Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis
    Divi's Laboratories Ltd.
    Divis: A Megacap Multibagger - SOIC
    View the discussion on ValuePickr
    Nutraceuticals- Industry Overview - Value Educator
    Detailed Analysis Of Divi's Labs & Business Model - Value Educator
    Detailed analysis on Divi’s Laboratories - A Mega Cap Compounding Machine - Value Educator
    Divi's In A Nutshell - Harsh Doshi
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline Timeline